Clinical trials in T-Cell lymphoma

The list below shows The Lymphoma Group's current clinical trials open for recruitment for T-Cell lymphoma patients.

If you would like to know how to access our trials, please see how to contact us.

• PROCLIPI - A non-medicinal (observational) clinical trial involving collecting data on patients with mycosis fungoides (primary cutaneous T cell lymphoma) and Sézary syndrome (SS), to help determine how we manage future patients.A non-medicinal (observational) clinical trial involving collecting data on patients with mycosis fungoides (primary cutaneous T cell lymphoma) and Sézary syndrome (SS), to help determine how we manage future patients.

• SGN35-032 - A phase 2 trial of brentuximab vedotin plus chemotherapy in people with peripheral T-cell lymphoma.

• StepPharma/STP938 – Testing STP938 in people with T-cell and B-cell lymphomas that has relapsed or is refractory
  
  
• ASTX660-003 – Testing Tolinapant in combination with other drugs in patients with relapsed or refractory PTCL
  
  
• CCS1477 – Testing CCS1477 in blood cancers, including relapsed or refractory non-Hodgkin lymphoma

With special thanks to the following:

For further information on each trial, please visit the Find a trial page on Lymphoma Action’s website.